Inducing AKI by injecting 20mg/kg of cisplatin in TLR2 and TLR4 knock-out (KO) mice showed TLR-2 KO mice with a 20% survival rate and TLR4 KO and wild-type mice with an 80% survival rate with minor differences. This evidence concerns the gene TLR4 and acute kidney injury.